Viscoelastic Properties of Respiratory and Peripheral Muscles of COPD Patients
NCT ID: NCT06580353
Last Updated: 2024-11-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2024-01-01
2024-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Investigation of the Cervical Region Biomechanics in Patients With Chronic Obstructive Pulmonary Disease
NCT06246370
The Viscoelastic Properties of Lower Extremity's Muscles
NCT04289129
Mechanical Properties of Peripheral and Accessory Respiratory Muscles in Chronic Obstructive Pulmonary Disease Patients
NCT06201403
The Effect of Respiratory Muscle Strength and Functional Capacity on Posture and Balance
NCT05005533
The Effects of Different Physiotherapy Approaches in Stable COPD Patients.
NCT05335304
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
COPD group
Patients with COPD who presented to the chest diseases polyclinic and whose symptoms of cough, sputum and/or dyspnoea accompanied by tachypnoea and/or tachycardia had not worsened in the last 14 days were defined as 'Stable COPD group' \[
No interventions assigned to this group
Control group
The control group was defined as those who did not have any systemic disease and who were normal at the end of the polyclinic examination who applied to the chest diseases polyclinic.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* body mass index (BMI) between 18.5-29.9 kg/m2,
* stable COPD patients
Exclusion Criteria
* having undergone any neurological, orthopaedic or thoracic surgery,
* presence of malignancy in any organ,
* presence of comorbidities affecting muscle atrophy (myasthenia gravis, muscular dystrophy, etc.).
40 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gaziantep Islam Science and Technology University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Çağtay Maden
Assistant professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gaziantep İslamic Science and Technology University
Gaziantep, Şahinbey, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023/391
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.